Exane Derivatives’s CVS Health CVS Stock Holding History

Exane Derivatives’s Portfolio CVS Stock Details CVS Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$426K	Buy	4,597 +3,885	+546%	+$360K	0.24%	103
2022 Q1	$72.1K	Sell	712 -363	-34%	-$36.7K	0.02%	516
2021 Q4	$111K	Buy	1,075 +744	+225%	+$76.8K	0.03%	426
2021 Q3	$28.1K	Hold	331	–	–	0.01%	654
2021 Q2	$27K	Buy	+331	New	+$27K	0.01%	674
2021 Q1	–	Sell	-1,511	Closed	-$103K	–	917
2020 Q4	$103K	Buy	1,511 +12	+0.8%	+$820	0.03%	386
2020 Q3	$87.5K	Sell	1,499 -6,759	-82%	-$395K	0.03%	298
2020 Q2	$537K	Buy	8,258 +4,012	+94%	+$261K	0.14%	115
2020 Q1	$252K	Sell	4,246 -2,543	-37%	-$151K	0.07%	160
2019 Q4	$511K	Sell	6,789 -10,426	-61%	-$785K	0.09%	156
2019 Q3	$1.09M	Buy	17,215 +3,868	+29%	+$244K	0.19%	100
2019 Q2	$727K	Buy	13,347 +10,303	+338%	+$561K	0.13%	123
2019 Q1	$164K	Sell	3,044 -18,003	-86%	-$971K	0.03%	228
2018 Q4	$1.38M	Sell	21,047 -1,924	-8%	-$126K	0.25%	84
2018 Q3	$1.81M	Sell	22,971 -33,371	-59%	-$2.63M	0.34%	73
2018 Q2	$3.62M	Buy	56,342 +22,154	+65%	+$1.43M	0.61%	21
2018 Q1	$2.14M	Buy	34,188 +22,543	+194%	+$1.41M	0.43%	53
2017 Q4	$844K	Buy	11,645 +11,079	+1,957%	+$803K	0.15%	102
2017 Q3	$46K	Sell	566 -1,961	-78%	-$159K	0.01%	283
2017 Q2	$203K	Buy	2,527 +1,045	+71%	+$84.1K	0.04%	177
2017 Q1	$116K	Sell	1,482 -141	-9%	-$11.1K	0.03%	204
2016 Q4	$128K	Sell	1,623 -87,370	-98%	-$6.89M	0.03%	208
2016 Q3	$7.92M	Buy	88,993 +86,997	+4,359%	+$7.74M	1.19%	29
2016 Q2	$191K	Sell	1,996 -240	-11%	-$23K	0.03%	205
2016 Q1	$232K	Sell	2,236 -637	-22%	-$66.1K	0.03%	162
2015 Q4	$281K	Buy	2,873 +1,069	+59%	+$105K	0.04%	128
2015 Q3	$174K	Sell	1,804 -224,828	-99%	-$21.7M	0.02%	172
2015 Q2	$23.8M	Buy	226,632 +14,062	+7%	+$1.47M	2.56%	6
2015 Q1	$21.9M	Buy	212,570 +71,612	+51%	+$7.39M	2.42%	15
2014 Q4	$13.6M	Buy	+140,958	New	+$13.6M	1.88%	8